Deelo vs Tempus: Disease Analysis Software Compared for 2026

Businesses looking for disease analysis software often narrow their search to Tempus — and for good reason. Massive clinical and molecular dataset for precision medicine insights. But not every team is the ideal Tempus buyer. Deelo takes a fundamentally different approach: instead of selling a single-purpose tool, it bundles Disease Analysis with 50+ integrated business apps under one subscription.

Tempus is best known for its position in the Disease Analysis space. Strengths commonly cited by buyers include: Massive clinical and molecular dataset for precision medicine insights; Genomic sequencing and biomarker analysis for targeted therapy matching; Strong partnerships with oncology centers and pharmaceutical companies. The typical price range is Custom institutional pricing, and it is best suited for oncology programs and research institutions focused on precision medicine and genomics. Trade-offs buyers often mention — your mileage may vary depending on your workflow — include: Primarily oncology and genomics focused — limited general diagnostic use; No practice management, scheduling, CRM, or business operations platform; Data-driven insights require institutional partnerships and integrations.

Deelo is an all-in-one business platform that provides Disease Analysis alongside CRM, invoicing, scheduling, field service, marketing, helpdesk, and dozens more apps — all connected through a unified data layer. Instead of patching together five or six SaaS subscriptions, teams run their entire operation from Deelo at a fraction of the combined cost.

Choose Tempus if oncology programs and research institutions focused on precision medicine and genomics and you do not need tools outside Disease Analysis. Choose Deelo if you want CRM, invoicing, scheduling, and Disease Analysis in one place without paying for multiple subscriptions. Deelo is particularly strong for small and mid-size businesses that are tired of juggling disconnected tools and want one source of truth.

Both platforms are capable Disease Analysis tools, but they serve different needs. Tempus is a deep, focused Disease Analysis tool at Custom institutional pricing. Deelo is a full business platform starting at $19/seat/mo that includes Disease Analysis plus 50+ additional apps. If you are currently paying for Disease Analysis and separate tools for CRM, invoicing, and scheduling, switching to Deelo can simplify your stack and save money.